| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 06/04/1997 | EP0776337A1 Growth differentiation factor-11 |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776218A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 06/04/1997 | EP0776210A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 06/04/1997 | EP0691980B1 7-deazapurine modified oligonucleotides |
| 06/04/1997 | EP0575387B1 Extraction system |
| 06/04/1997 | CN1151185A Nucleotide sequences of pestivirus strains, polypeptides encoded by these squences and use thereof for diagnosis and prevention of pestivirus infections |
| 06/03/1997 | US5635618 Expression construct conferring root specific expresssion in plants comprising regulatory sequence of maize alpha-tubulin consisting of specified nucleotides |
| 06/03/1997 | US5635615 High affinity HIV nucleocapsid nucleic acid ligands |
| 06/03/1997 | US5635603 Antibody fragment covalently bound to diagnostic or therapeutic principle through carbohydrate moiety |
| 06/03/1997 | US5635488 Suited as diagnostics, therapeutics and research agents |
| 06/03/1997 | US5635400 Minimally cross-hybridizing sets of oligonucleotide tags |
| 06/03/1997 | US5635382 Method for enhancing transmembrane transport of exogenous molecules |
| 06/03/1997 | US5635347 Rapid assays for amplification products |
| 06/03/1997 | US5635177 Useful in enabling role of tyrosine kinase receptor in cell growth and differentiation |
| 06/03/1997 | US5635160 Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
| 05/29/1997 | WO1997019097A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | WO1997019092A1 Improved process for the synthesis of oligomeric compounds |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2236825A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/28/1997 | EP0775748A2 Preparation of D-alpha-amino acids, using bacteria transformed with the carbamoylase-hydantoinase operon |
| 05/28/1997 | EP0775747A2 Genes of the hop latent virus and methods for detecting the same |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 05/28/1997 | EP0775204A1 Antitumor antisense oligonucleotides |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
| 05/28/1997 | EP0775150A1 Endotoxin reduction or removal process |
| 05/28/1997 | EP0775149A1 Novel protecting groups and use thereof in an improved process for oligonucleotide synthesis |
| 05/28/1997 | EP0774902A1 Antisense and triplex therapeutic agents and methods |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/27/1997 | US5633364 N4 -substituted 2'-deoxycytidine compounds, oligonucleotides including N4 -labeled 2'-deoxycytidines, and a process for making oligonucleotides with N-modified 2'-deoxycytidines |
| 05/27/1997 | US5633361 Oligonucleotides |
| 05/27/1997 | US5633360 Contains at least two nucleoside residues and internucleotide linkages |
| 05/27/1997 | US5633354 Phosphoramidite derivatives of texaphyrins |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | US5632970 Fluoresence detection using texaphyrins |
| 05/27/1997 | US5632957 Molecular biological diagnostic systems including electrodes |
| 05/27/1997 | CA2070591C Yogourt |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | WO1997018226A1 Integrated nucleic acid hybridization devices based upon active surface chemistry |
| 05/22/1997 | CA2237528A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | CA2235762A1 Integrated nucleic acid hybridization devices based upon active surface chemistry |
| 05/22/1997 | CA2234661A1 Mimotopes and anti-mimotopes of human platelet glycoprotein ib/ix |
| 05/21/1997 | EP0774517A1 Method of individual discrimination by polymerase chain reaction using mi primer |
| 05/21/1997 | EP0774516A2 Fluorescence polarization detection of nucleic acid amplification |
| 05/21/1997 | EP0774515A2 Fluorescence polarization detection of nucleic acids |
| 05/21/1997 | EP0774513A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
| 05/21/1997 | EP0774512A2 A method for production of protein using molecular chaperon |
| 05/21/1997 | EP0774511A1 Methods of producing members of specific binding pairs |
| 05/21/1997 | EP0773995A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof |
| 05/21/1997 | EP0773953A1 Combinatorial libraries of molecules and methods for producing same |
| 05/21/1997 | EP0773951A1 Dinucleoside-5',5'-pyrophosphates |
| 05/21/1997 | EP0773950A1 Linked peptide nucleic acids |
| 05/21/1997 | EP0660844A4 Isolated nucleotide sequences for identifying neisseria gonorrhoeae. |
| 05/21/1997 | CN1150458A Hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF for hematopoietic stimulation |
| 05/21/1997 | CN1150457A Gene imparting flocculability to yeast and gene product |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150431A Purification of oligodeoxynucleotide phosphorothioates using anion exchange chromatography |
| 05/20/1997 | US5631362 Forming dna and rna by polycondensation of mononucleotides with protective sulfonylalkyl dimethylaminonaphthalene groups for alkoxy furan groups |
| 05/20/1997 | US5631361 Method of synthesizing radioisotopically labeled oligonucleotides by direct solid-phase 5' phosphitylation |
| 05/20/1997 | US5631236 Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| 05/20/1997 | US5631143 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 05/20/1997 | US5631135 Oligonucleotide N3'→P5' phosphoramidates: hybridization and nuclease resistance properties |
| 05/15/1997 | WO1997017470A1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 05/15/1997 | WO1997017440A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | WO1997010332A3 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 05/15/1997 | CA2236711A1 Method for the simultaneous detection of polygenes |
| 05/15/1997 | CA2235631A1 Neuropeptide y-y5 receptor |
| 05/14/1997 | EP0773294A2 Efficient directional genetic cloning system |
| 05/14/1997 | EP0773293A2 Genetically engineered tumour cell lines and their use in the screening of antitumour-compositions |
| 05/14/1997 | EP0773290A2 Novel LDL receptor analog protein and the gene coding therefor |
| 05/14/1997 | EP0773289A2 Asialoglycoprotein receptor derivatives and their use |
| 05/14/1997 | EP0773227A1 Diverse collections of oligomers in use to prepare drugs, diagnostic reagents, pesticides or herbicides |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |
| 05/14/1997 | EP0772680A1 A polynucleotide herpes virus vaccine |
| 05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 05/14/1997 | EP0772625A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 05/14/1997 | EP0772623A1 Soluble combinatorial libraries |
| 05/14/1997 | EP0772622A1 5'-dithio-modified oligonucleotides |
| 05/14/1997 | EP0772621A2 Oligonucleotides with anti-mdr-1 gene activity |
| 05/14/1997 | EP0772620A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 05/14/1997 | EP0772619A1 Immunomodulatory oligonucleotides |
| 05/14/1997 | EP0772454A1 Antisense oligonucleotides against hepatitis b viral replication |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0677111B1 Novel proteinaceous particles |
| 05/14/1997 | CN1149889A Isolated nucleic acid molecule with codes for tumor rejection antigen precursor and uses thereof |
| 05/14/1997 | CN1149888A 流感疫苗 Influenza vaccination |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/13/1997 | US5629469 Peptide virgiferin and variations; recombinant dna molecule with nucleic acid sequence encoding peptide; transgenic plant with foreign gene encoding peptide; combatting insects with peptide; host cell transformed with vector as described |
| 05/13/1997 | US5629454 Conformationally locked nucleoside analogues |
| 05/13/1997 | US5629177 Method for the enzymatic synthesis of oligonucleotides using thermostable 3'-phosphatase |